Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/projekte/334-multicenter-randomized-double-blind-placebo-controlled-parallel-group-study-to-evaluate-the-efficacy-safety-tolerability-of-two-doses-of-act-128800-an-oral-s1p1-receptor-agonist-administered-up-to-twenty-eight-weeks-in-patients-with-moderate-to-severe-chronic-plaque-psoriasis